# Lafayette Pharmacal, Inc.

- Location (FDA's records): Lafayette, IN
- FDA decisions: 4 (1986–1993): 4 510(k) clearances
- Product codes: KGC (1), FCE (1), FFX (1), FGD (1)
- Predicates its devices cite: 0 (0 its own); citations of its devices by later devices: 2 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms that cite its devices most
- Medifactia AB: 1 (https://510kreport.com/company/medifactia)
- Chess Medical, Inc.: 1 (https://510kreport.com/company/chess-medical)

## Its most-cited devices
- K881609: Sitzmarks (1988), cited by 1
- K884379: Maglinte Enteroclysis Catheter (1989), cited by 1

## Recent decisions
- K931896: Pro-Flo System (Aug 26, 1993)
- K884379: Maglinte Enteroclysis Catheter (Feb 28, 1989)
- K881609: Sitzmarks (Jul 8, 1988)
- K860441: Entrokit with Maglinte Catheter (Mar 12, 1986)

Source page: https://510kreport.com/company/lafayette-pharmacal